Billing for naloxone distributed in an emergency department

Having trouble viewing this email? View it as a Web page.

Health Care Authority (HCA) logo

Billing for naloxone distributed in an emergency department

Effective January 1 2022, hospital emergency departments (EDs) may distribute prepackaged opioid overdose reversal medication, naloxone, to individuals at risk of an opioid overdose.

For naloxone distributed to Apple Health Fee-For-Service (FFS) clients in the ED, bill as a separate line item with one of the following HCPCS and the National Drug Code (NDC) of the product distributed:

HCPCS Drug
J2310 Naloxone injection
J3490 Naloxone 4mg nasal spray
G1028 Naloxone 8mg nasal spray

This information will be added to the Outpatient Hospital Services Billing Guide no later than February 15, 2022.

*Note: Reimbursement for naloxone will not be included in the ED bundled rate.

Questions

For questions, please email HCA.